Global Epigenetics Market Size study & Forecast, by Product (Instruments, Kits and Reagents, Others), by Application (Oncology, Autoimmune Diseases, Metabolic Diseases, CNS/Pain Diseases, Cardiovascular Diseases), by Technology (Methylation, Acetylation, Phosphorylation, Other Technologies) and Regional Analysis, 2023-2030
Global Epigenetics Market is valued approximately at USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.1% over the forecast period 2023-2030. Epigenetics is the study of gene changes that may affect common gene mutations. Epigenetic mechanisms are being linked to an increasing number of chronic diseases and disorders, including cardiovascular diseases, autoimmune diseases, and neurodegenerative disorders, in addition to environmental factors and nutrition, which affect epigenetic processes such as DNA methylation, histone modification, and non-coding RNA. Innovative therapeutic strategies can now be developed because of the identification of numerous cutting-edge therapeutic targets through epigenetic research. Factors such as rising expenditure in Research and Development, Increasing Cancer cases and increasing uses of non-oncological applications of epigenetics are expected to drive the growth of the epigenetics market in the forecast year 2023-2030.
According to Statista, cancer is one of the biggest health issues in the world that affects millions of people of all ages and genders and has a significant negative influence on quality of life. The incidence of new cancer cases is rising along with the average age of the world's population, which results in more deaths each year. Globally, there were around 10 million cancer-related deaths in 2020; and this number is predicted to rise to over 16 million, by 2040. Rising healthcare research & development expenditure globally is also anticipated to fuel market expansion. According to the World Health Organization in December 2021, the gross domestic research and development expenditure (health GERD) as a percentage of gross domestic product (GDP) in high-income nations was 0.21% and 0.02% for upper middle- and low-income nations. Moreover, the increasing demand in patients’ base for personalized medicine and high use of epigenetics in therapeutics and drug development may create lucrative opportunities for the market in the forecast period. However, the lack of skilled professionals working in this field stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Epigenetics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the presence of key market players, significant investments in research and development, and a rise in cancer cases. According to the United States National Institute of Health, USD 1,098 million had been allocated for cancer genomics research as of December 2021, thus driving the growth of the market. However, Asia Pacific is expected to be the fastest growing region during the forecast period, owing to rising awareness in epigenetics, prevalence of key players in developing countries of Asia Pacific, and developing infrastructure for research and clinical settings.
Major market player included in this report are:
Abcam PLC
Illumina Inc.
Bio-Rad Technologies
Hologic Inc (Diagenode Inc.)
Thermo Fisher Scientific
Perkin Elmer
New England Biolabs
Active Motiff
Zymo Research Corporation
Qiagen NV
Recent Developments in the Market:
In December 2022, Merck Announces Mersana Therapeutics Collaboration to Create New Immunostimulatory Antibody-Drug Conjugates.
In August 2022, Merck KGaA, a leading science and technology company, signed a definitive agreement to acquire the chemical division of Mecaro Co. Ltd. (Mecaro), a publicly traded Korean manufacturer of heater blocks and chemical precursors for semiconductors.
In February 2022, Element Biosciences, Inc., the creator of a novel and innovative DNA sequencing technology partnered with Dovetail Genomics to showcase the benefits and effectiveness of Dovetail’s proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element's AVITI System.
Global Epigenetics Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Technology, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Instruments
Kits and Reagents
Others
By Application:
Oncology
Autoimmune Diseases
Metabolic Diseases
CNS/Pain Diseases
Cardiovascular Diseases
By Technology:
Methylation
Acetylation
Phosphorylation
Other Technologies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
According to Statista, cancer is one of the biggest health issues in the world that affects millions of people of all ages and genders and has a significant negative influence on quality of life. The incidence of new cancer cases is rising along with the average age of the world's population, which results in more deaths each year. Globally, there were around 10 million cancer-related deaths in 2020; and this number is predicted to rise to over 16 million, by 2040. Rising healthcare research & development expenditure globally is also anticipated to fuel market expansion. According to the World Health Organization in December 2021, the gross domestic research and development expenditure (health GERD) as a percentage of gross domestic product (GDP) in high-income nations was 0.21% and 0.02% for upper middle- and low-income nations. Moreover, the increasing demand in patients’ base for personalized medicine and high use of epigenetics in therapeutics and drug development may create lucrative opportunities for the market in the forecast period. However, the lack of skilled professionals working in this field stifles market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Epigenetics Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the presence of key market players, significant investments in research and development, and a rise in cancer cases. According to the United States National Institute of Health, USD 1,098 million had been allocated for cancer genomics research as of December 2021, thus driving the growth of the market. However, Asia Pacific is expected to be the fastest growing region during the forecast period, owing to rising awareness in epigenetics, prevalence of key players in developing countries of Asia Pacific, and developing infrastructure for research and clinical settings.
Major market player included in this report are:
Abcam PLC
Illumina Inc.
Bio-Rad Technologies
Hologic Inc (Diagenode Inc.)
Thermo Fisher Scientific
Perkin Elmer
New England Biolabs
Active Motiff
Zymo Research Corporation
Qiagen NV
Recent Developments in the Market:
In December 2022, Merck Announces Mersana Therapeutics Collaboration to Create New Immunostimulatory Antibody-Drug Conjugates.
In August 2022, Merck KGaA, a leading science and technology company, signed a definitive agreement to acquire the chemical division of Mecaro Co. Ltd. (Mecaro), a publicly traded Korean manufacturer of heater blocks and chemical precursors for semiconductors.
In February 2022, Element Biosciences, Inc., the creator of a novel and innovative DNA sequencing technology partnered with Dovetail Genomics to showcase the benefits and effectiveness of Dovetail’s proximity ligation-based next-generation sequencing (NGS) library prep solutions on Element's AVITI System.
Global Epigenetics Market Report Scope:
Historical Data – 2020 - 2021
Base Year for Estimation – 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Product, Application, Technology, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Instruments
Kits and Reagents
Others
By Application:
Oncology
Autoimmune Diseases
Metabolic Diseases
CNS/Pain Diseases
Cardiovascular Diseases
By Technology:
Methylation
Acetylation
Phosphorylation
Other Technologies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Epigenetics Market, by region, 2020-2030 (USD Billion)
1.2.2. Epigenetics Market, by Product, 2020-2030 (USD Billion)
1.2.3. Epigenetics Market, by Application, 2020-2030 (USD Billion)
1.2.4. Epigenetics Market, by Technology, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Technology
1.5. Research Assumption
CHAPTER 2. GLOBAL EPIGENETICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL EPIGENETICS MARKET DYNAMICS
3.1. Epigenetics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising funding in Research and Development
3.1.1.2. Increasing Cancer cases
3.1.1.3. Increasing uses of non-oncological applications of epigenetics
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Rising demand of patients for personalized medicine
3.1.3.2. High use in therapeutics and drug development
CHAPTER 4. GLOBAL EPIGENETICS MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL EPIGENETICS MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Epigenetics Market by Product, Performance - Potential Analysis
5.3. Global Epigenetics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Epigenetics Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Kits and Reagents
5.4.3. Others
CHAPTER 6. GLOBAL EPIGENETICS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Epigenetics Market by Application, Performance - Potential Analysis
6.3. Global Epigenetics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Epigenetics Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Autoimmune Diseases
6.4.3. Metabolic Diseases
6.4.4. CNS/Pain Diseases
6.4.5. Cardiovascular Diseases
CHAPTER 7. GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Epigenetics Market by Technology, Performance - Potential Analysis
7.3. Global Epigenetics Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
7.4. Epigenetics Market, Sub Segment Analysis
7.4.1. Methylation
7.4.2. Acetylation
7.4.3. Phosphorylation
7.4.4. Other Technologies
CHAPTER 8. GLOBAL EPIGENETICS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Epigenetics Market, Regional Market Snapshot
8.4. North America Epigenetics Market
8.4.1. U.S. Epigenetics Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Epigenetics Market
8.5. Europe Epigenetics Market Snapshot
8.5.1. U.K. Epigenetics Market
8.5.2. Germany Epigenetics Market
8.5.3. France Epigenetics Market
8.5.4. Spain Epigenetics Market
8.5.5. Italy Epigenetics Market
8.5.6. Rest of Europe Epigenetics Market
8.6. Asia-Pacific Epigenetics Market Snapshot
8.6.1. China Epigenetics Market
8.6.2. India Epigenetics Market
8.6.3. Japan Epigenetics Market
8.6.4. Australia Epigenetics Market
8.6.5. South Korea Epigenetics Market
8.6.6. Rest of Asia Pacific Epigenetics Market
8.7. Latin America Epigenetics Market Snapshot
8.7.1. Brazil Epigenetics Market
8.7.2. Mexico Epigenetics Market
8.8. Middle East & Africa Epigenetics Market
8.8.1. Saudi Arabia Epigenetics Market
8.8.2. South Africa Epigenetics Market
8.8.3. Rest of Middle East & Africa Epigenetics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abcam PLC
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Illumina Inc.
9.3.3. Bio-Rad Technologies
9.3.4. Hologic Inc (Diagenode Inc.)
9.3.5. Thermo Fisher Scientific
9.3.6. Perkin Elmer
9.3.7. New England Biolabs
9.3.8. Active Motiff
9.3.9. Zymo Research Corporation
9.3.10. Qiagen NV
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
12. List ofTables
TABLE 1. Global Epigenetics Market, report scope
TABLE 2. Global Epigenetics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Epigenetics Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Epigenetics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Epigenetics Market estimates & forecasts by Technology 2020-2030 (USD Billion)
TABLE 6. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. 12. List ofsecondary sources, used in the study of global Epigenetics Market
TABLE 71. 12. List ofprimary sources, used in the study of global Epigenetics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
12. List offigures
FIG 1. Global Epigenetics Market, research Technologyology
FIG 2. Global Epigenetics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast Technologys
FIG 4. Global Epigenetics Market, key trends 2022
FIG 5. Global Epigenetics Market, growth prospects 2023-2030
FIG 6. Global Epigenetics Market, porters 5 force model
FIG 7. Global Epigenetics Market, pest analysis
FIG 8. Global Epigenetics Market, value chain analysis
FIG 9. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Epigenetics Market, regional snapshot 2020 & 2030
FIG 15. North America Epigenetics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Epigenetics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Epigenetics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Epigenetics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Epigenetics Market 2020 & 2030 (USD Billion)
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Epigenetics Market, by region, 2020-2030 (USD Billion)
1.2.2. Epigenetics Market, by Product, 2020-2030 (USD Billion)
1.2.3. Epigenetics Market, by Application, 2020-2030 (USD Billion)
1.2.4. Epigenetics Market, by Technology, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Technology
1.5. Research Assumption
CHAPTER 2. GLOBAL EPIGENETICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL EPIGENETICS MARKET DYNAMICS
3.1. Epigenetics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising funding in Research and Development
3.1.1.2. Increasing Cancer cases
3.1.1.3. Increasing uses of non-oncological applications of epigenetics
3.1.2. Market Challenges
3.1.2.1. Lack of skilled professionals
3.1.3. Market Opportunities
3.1.3.1. Rising demand of patients for personalized medicine
3.1.3.2. High use in therapeutics and drug development
CHAPTER 4. GLOBAL EPIGENETICS MARKET: INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economic
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
CHAPTER 5. GLOBAL EPIGENETICS MARKET, BY PRODUCT
5.1. Market Snapshot
5.2. Global Epigenetics Market by Product, Performance - Potential Analysis
5.3. Global Epigenetics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Epigenetics Market, Sub Segment Analysis
5.4.1. Instruments
5.4.2. Kits and Reagents
5.4.3. Others
CHAPTER 6. GLOBAL EPIGENETICS MARKET, BY APPLICATION
6.1. Market Snapshot
6.2. Global Epigenetics Market by Application, Performance - Potential Analysis
6.3. Global Epigenetics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Epigenetics Market, Sub Segment Analysis
6.4.1. Oncology
6.4.2. Autoimmune Diseases
6.4.3. Metabolic Diseases
6.4.4. CNS/Pain Diseases
6.4.5. Cardiovascular Diseases
CHAPTER 7. GLOBAL EPIGENETICS MARKET, BY TECHNOLOGY
7.1. Market Snapshot
7.2. Global Epigenetics Market by Technology, Performance - Potential Analysis
7.3. Global Epigenetics Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
7.4. Epigenetics Market, Sub Segment Analysis
7.4.1. Methylation
7.4.2. Acetylation
7.4.3. Phosphorylation
7.4.4. Other Technologies
CHAPTER 8. GLOBAL EPIGENETICS MARKET, REGIONAL ANALYSIS
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Epigenetics Market, Regional Market Snapshot
8.4. North America Epigenetics Market
8.4.1. U.S. Epigenetics Market
8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Epigenetics Market
8.5. Europe Epigenetics Market Snapshot
8.5.1. U.K. Epigenetics Market
8.5.2. Germany Epigenetics Market
8.5.3. France Epigenetics Market
8.5.4. Spain Epigenetics Market
8.5.5. Italy Epigenetics Market
8.5.6. Rest of Europe Epigenetics Market
8.6. Asia-Pacific Epigenetics Market Snapshot
8.6.1. China Epigenetics Market
8.6.2. India Epigenetics Market
8.6.3. Japan Epigenetics Market
8.6.4. Australia Epigenetics Market
8.6.5. South Korea Epigenetics Market
8.6.6. Rest of Asia Pacific Epigenetics Market
8.7. Latin America Epigenetics Market Snapshot
8.7.1. Brazil Epigenetics Market
8.7.2. Mexico Epigenetics Market
8.8. Middle East & Africa Epigenetics Market
8.8.1. Saudi Arabia Epigenetics Market
8.8.2. South Africa Epigenetics Market
8.8.3. Rest of Middle East & Africa Epigenetics Market
CHAPTER 9. COMPETITIVE INTELLIGENCE
9.1. Key Company SWOT Analysis
9.1.1. Company
9.1.2. Company
9.1.3. Company
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abcam PLC
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Illumina Inc.
9.3.3. Bio-Rad Technologies
9.3.4. Hologic Inc (Diagenode Inc.)
9.3.5. Thermo Fisher Scientific
9.3.6. Perkin Elmer
9.3.7. New England Biolabs
9.3.8. Active Motiff
9.3.9. Zymo Research Corporation
9.3.10. Qiagen NV
CHAPTER 10. RESEARCH PROCESS
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
12. List ofTables
TABLE 1. Global Epigenetics Market, report scope
TABLE 2. Global Epigenetics Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Epigenetics Market estimates & forecasts by Product 2020-2030 (USD Billion)
TABLE 4. Global Epigenetics Market estimates & forecasts by Application 2020-2030 (USD Billion)
TABLE 5. Global Epigenetics Market estimates & forecasts by Technology 2020-2030 (USD Billion)
TABLE 6. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Epigenetics Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Epigenetics Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Epigenetics Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Epigenetics Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. 12. List ofsecondary sources, used in the study of global Epigenetics Market
TABLE 71. 12. List ofprimary sources, used in the study of global Epigenetics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
12. List offigures
FIG 1. Global Epigenetics Market, research Technologyology
FIG 2. Global Epigenetics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast Technologys
FIG 4. Global Epigenetics Market, key trends 2022
FIG 5. Global Epigenetics Market, growth prospects 2023-2030
FIG 6. Global Epigenetics Market, porters 5 force model
FIG 7. Global Epigenetics Market, pest analysis
FIG 8. Global Epigenetics Market, value chain analysis
FIG 9. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Epigenetics Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Epigenetics Market, regional snapshot 2020 & 2030
FIG 15. North America Epigenetics Market 2020 & 2030 (USD Billion)
FIG 16. Europe Epigenetics Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Epigenetics Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Epigenetics Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Epigenetics Market 2020 & 2030 (USD Billion)
12. List oftables and figures and dummy in nature, final lists may vary in the final deliverable
